Michael Mosteller

2.7k total citations · 1 hit paper
34 papers, 1.9k citations indexed

About

Michael Mosteller is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Michael Mosteller has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Physiology. Recurrent topics in Michael Mosteller's work include Drug-Induced Adverse Reactions (8 papers), Autoimmune Bullous Skin Diseases (5 papers) and Cardiovascular Function and Risk Factors (5 papers). Michael Mosteller is often cited by papers focused on Drug-Induced Adverse Reactions (8 papers), Autoimmune Bullous Skin Diseases (5 papers) and Cardiovascular Function and Risk Factors (5 papers). Michael Mosteller collaborates with scholars based in United States, United Kingdom and Japan. Michael Mosteller's co-authors include Richard M. Schieken, Arlene R. Hughes, Eric Lai, William Spreen, William B. Moskowitz, Allen D. Roses, John K. Hewitt, Seth Hetherington, Linda M. Thurmond and Katherine L. Baker-Neblett and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Michael Mosteller

34 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

2002 583 citations Seth Hetherington, Arlene R. Hughes et al. The Lancet profile →

Peers

Countries citing papers authored by Michael Mosteller

Since Specialization

Citations

This map shows the geographic impact of Michael Mosteller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mosteller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mosteller more than expected).

Fields of papers citing papers by Michael Mosteller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Mosteller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mosteller. The network helps show where Michael Mosteller may publish in the future.

Co-authorship network of co-authors of Michael Mosteller

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Mosteller. A scholar is included among the top collaborators of Michael Mosteller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Mosteller. Michael Mosteller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic evaluation of the effect of GLCCI1 rs37973 on corticosteroid response in chronic obstructive pulmonary disease 2017 ·Michael Mosteller, Maarten van den Berge, Louise K. Hosking, Wim Timens, Pieter S. Hiemstra, Courtney Crim, Dirkje S. Postma, Soumitra Ghosh	6
2	No evidence of large genetic effects on steroid response in asthma patients 2016 ·Journal of Allergy and Clinical Immunology ·Michael Mosteller, Louise K. Hosking, (unknown), Judong Shen, Kijoung Song, Matthew R. Nelson, Soumitra Ghosh	25
3	Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir 2014 ·European Journal of Clinical Pharmacology ·Ivy Song, Julie Borland, Shuguang Chen, (unknown), Yu Lou, David Wilfret, Toshihiro Wajima, Paul Savina, Amanda Peppercorn, Stephen Castellino, David S. Wagner, Louise K. Hosking, Michael Mosteller, Justin P. Rubio, Stephen C. Piscitelli	30
4	Exploring the roles of UGT1A1 and UGT1A3 in oral clearance of GSK2190915, a 5-lipoxygenase-activating protein inhibitor 2014 ·Pharmacogenetics and Genomics ·Michael Mosteller, Lynn D. Condreay, (unknown), Claire Ambery, Misba Beerahee, Soumitra Ghosh	5
5	Genetic analysis of asthma exacerbations 2013 ·Annals of Allergy Asthma & Immunology ·Wayne H. Anderson, Beena T. Koshy, Lingkang Huang, Michael Mosteller, Sandra W. Stinnett, Lynn D. Condreay, Héctor Ortega	3
6	Saliva sampling in global clinical studies: the impact of low sampling volume on performance of DNA in downstream genotyping experiments 2013 ·BMC Medical Genomics ·David Pulford, Michael Mosteller, (unknown), (unknown), Anita J. Nelsen	18
7	Distribution of HLA‐B alleles in a Ugandan HIV‐infected adult population: NORA pharmacogenetic substudy of DART 2010 ·Tropical Medicine & International Health ·Paula Munderi, Wendy Snowden, A. Sarah Walker, Cissy Kityo, Michael Mosteller, Geoffrey Kabuye, (unknown), Francis Ssali, Charles F. Gilks, Arlene R. Hughes, (unknown)	17
8	Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility 2008 ·The Pharmacogenomics Journal ·Arlene R. Hughes, William Spreen, Michael Mosteller, Liling Warren, Eric Lai, Cynthia H. Brothers, Charles Cox, Anita J. Nelsen, Scott Hughes, D. Thorborn, Britt Stancil, Seth Hetherington, Daniel K. Burns, A D Roses	61
9	Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions 2008 ·The Pharmacogenomics Journal ·Matthew R. Nelson, Silviu‐Alin Bacanu, Michael Mosteller, Ling-Ling Li, Clive Bowman, A D Roses, Eric Lai, Margaret G. Ehm	69
10	High sensitivity of HLA-B5701 in Whites and Blacks in immunologically-confirmed cases of abacavir hypersensitivity (ABC HSR) 2007 ·Murdoch Research Repository (Murdoch University)* ·Michael S. Saag, Ramani Balu, Philip S. Brachman, Britt Stancil, Michael Mosteller, Paul Wannamaker, Denise Sutherland‐Phillips, Emma Jane Phillips, S. Mallal, Mark S. Shaefer	8
11	Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazar 2007 ·Pharmacogenetics and Genomics ·Colin F. Spraggs, Alun D. McCarthy, Linda McCarthy, Guizhu Hong, Arlene R. Hughes, Xiwu Lin, Ganesh M. Sathe, (unknown), Christopher Traini, Stephanie Van Horn, Liling Warren, Michael Mosteller	11
12	Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations 2004 ·Pharmacogenomics ·Arlene R. Hughes, Michael Mosteller, Aruna T. Bansal, (unknown), Stephen Haneline, Eric Lai, (unknown), Trevor R. Scott, William Spreen, Liling Warren, Allen D. Roses, (unknown)	185
13	Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillance 2002 ·British Journal of Clinical Pharmacology ·C. Brazell, Andrew Freeman, Michael Mosteller	21
14	Genetic variations in HLA-B region and hypersensitivity reactions to abacavir breakdown → 2002 ·The Lancet ·Seth Hetherington, Arlene R. Hughes, Michael Mosteller, Denise Shortino, Katherine L. Baker-Neblett, William Spreen, Eric Lai, (unknown), (unknown), David J. Dow, Mary E. Fling, Michael Stocum, (unknown), Linda M. Thurmond, Allen D. Roses	583
15	APPLICATIONS OF PHARMACOGENETICS TO DRUG DEVELOPMENT: THE GLAXO WELLCOME EXPERIENCE^* 2000 ·Drug Metabolism Reviews ·(unknown), Andrew Freeman, (unknown), Michael Mosteller, Penelope K. Manasco	11
16	Univariate Genetic Analysis of Oxygen Transport Regulation in Children: The Medical College of Virginia Twin Study 1993 ·Pediatric Research ·William B. Moskowitz, Michael Mosteller, John K. Hewitt, Lindon J. Eaves, Walter E. Nance, Richard M. Schieken	3
17	Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia Twin Study) 1991 ·The American Journal of Cardiology ·Henri Verhaaren, Richard M. Schieken, Michael Mosteller, John K. Hewitt, Lindon J. Eaves, Walter E. Nance	116
18	Altered systolic and diastolic function in children after “successful” repair of coarctation of the aorta 1990 ·American Heart Journal ·William B. Moskowitz, Richard M. Schieken, Michael Mosteller, (unknown)	64
19	Genetic Analysis of Anthropometric Measures in 11-Year-Old Twins: The Medical College of Virginia Twin Study 1990 ·Pediatric Research ·Joann Bodurtha, Michael Mosteller, John K. Hewitt, Walter E. Nance, Lindon J. Eaves, William B. Moskowitz, Solomon H. Katz, Richard M. Schieken	67
20	Univariate genetic analysis of blood pressure in children (The Medical College of Virginia Twin Study) 1989 ·The American Journal of Cardiology ·Richard M. Schieken, Lindon J. Eaves, John K. Hewitt, Michael Mosteller, Joann Bodurtha, William B. Moskowitz, Walter E. Nance	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact